메뉴 건너뛰기




Volumn 135, Issue 9, 2009, Pages 1207-1213

Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas

Author keywords

Aggressive lymphomas; Antibody response; BCL 2; Immunogenicity

Indexed keywords

ACTININ; ACTININ ALPHA 1; CD20 ANTIBODY; CYCLIN D2; CYCLOPHOSPHAMIDE; DOXORUBICIN; E2IG3 PROTEIN; HGAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; LM02 PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PDE4B PROTEIN; PREDNISONE; PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN BCL XL; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 2; PROTEIN MCL 1; RITUXIMAB; SURVIVIN; UNCLASSIFIED DRUG; VACCINE; VINCRISTINE;

EID: 68649107079     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0561-0     Document Type: Article
Times cited : (2)

References (36)
  • 1
    • 0035881885 scopus 로고    scopus 로고
    • Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients
    • MH Andersen LO Pedersen B Capeller EB Brocker JC Becker SP Thor 2001 Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients Cancer Res 61 5964 5968
    • (2001) Cancer Res , vol.61 , pp. 5964-5968
    • Andersen, M.H.1    Pedersen, L.O.2    Capeller, B.3    Brocker, E.B.4    Becker, J.C.5    Thor, S.P.6
  • 2
    • 18944384287 scopus 로고    scopus 로고
    • Identification of an HLA-A1 restricted CTL epitope from Mcl-1 [5]
    • DOI 10.1038/sj.leu.2403743
    • MH Andersen P Kvistborg JC Becker SP Thor 2005 Identification of an HLA-A1 restricted CTL epitope from Mcl-1 Leukemia 19 1084 1085 10.1038/sj.leu.2403743 (Pubitemid 40862025)
    • (2005) Leukemia , vol.19 , Issue.6 , pp. 1084-1085
    • Andersen, M.H.1    Kvistborg, P.2    Becker, J.C.3    Thor, S.P.4
  • 7
    • 0037137510 scopus 로고    scopus 로고
    • HLA class I antigen loss, tumor immune escape and immune selection
    • DOI 10.1016/S0264-410X(02)00386-9, PII S0264410X02003869
    • M Campoli CC Chang S Ferrone 2002 HLA class I antigen loss, tumor immune escape and immune selection Vaccine 20 Suppl 4 A40 A45 10.1016/S0264-410X(02) 00386-9 (Pubitemid 35449404)
    • (2002) Vaccine , vol.20 , Issue.SUPPL. 4
    • Campoli, M.1    Chang, C.-C.2    Ferrone, S.3
  • 11
    • 38048998545 scopus 로고    scopus 로고
    • Antibody responses to survivin and their clinical significance in patients with head and neck cancer
    • 10.1002/hed.20652
    • M Eto S Kodama N Uemura M Suzuki 2007 Antibody responses to survivin and their clinical significance in patients with head and neck cancer Head Neck 29 1128 1135 10.1002/hed.20652
    • (2007) Head Neck , vol.29 , pp. 1128-1135
    • Eto, M.1    Kodama, S.2    Uemura, N.3    Suzuki, M.4
  • 14
    • 0030916669 scopus 로고    scopus 로고
    • The proto-oncogene Bcl-2 and its role in regulating apoptosis
    • DOI 10.1038/nm0697-614
    • G Kroemer 1997 The proto-oncogene Bcl-2 and its role in regulating apoptosis Nat Med 3 614 620 10.1038/nm0697-614 (Pubitemid 27264969)
    • (1997) Nature Medicine , vol.3 , Issue.6 , pp. 614-620
    • Kroemer, G.1
  • 15
    • 3342991899 scopus 로고    scopus 로고
    • A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein
    • DOI 10.1038/sj.bjc.6601875
    • AP Liggins PJ Brown K Asker K Pulford AH Banham 2004 A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein Br J Cancer 91 141 149 10.1038/sj.bjc.6601875 (Pubitemid 39013058)
    • (2004) British Journal of Cancer , vol.91 , Issue.1 , pp. 141-149
    • Liggins, A.P.1    Brown, P.J.2    Asker, K.3    Pulford, K.4    Banham, A.H.5
  • 17
    • 1542436707 scopus 로고    scopus 로고
    • Targeting BCL-2-related proteins in cancer therapy
    • MK Manion DM Hockenbery 2003 Targeting BCL-2-related proteins in cancer therapy Cancer Biol Ther 2 S105 S114
    • (2003) Cancer Biol Ther , vol.2
    • Manion, M.K.1    Hockenbery, D.M.2
  • 19
    • 34047217206 scopus 로고    scopus 로고
    • Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia
    • DOI 10.1200/JCO.2006.07.1191
    • S O'Brien JO Moore TE Boyd LM Larratt A Skotnicki B Koziner AA Chanan-Khan JF Seymour RG Bociek S Pavletic KR Rai 2007 Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia J Clin Oncol 25 1114 1120 10.1200/JCO.2006.07.1191 (Pubitemid 46596764)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.9 , pp. 1114-1120
    • O'Brien, S.1    Moore, J.O.2    Boyd, T.E.3    Larratt, L.M.4    Skotnicki, A.5    Koziner, B.6    Chanan-Khan, A.A.7    Seymour, J.F.8    Bociek, R.G.9    Pavletic, S.10    Rai, K.R.11
  • 21
    • 0036812659 scopus 로고    scopus 로고
    • Analysis of the B-cell repertoire against antigens expressed by human neoplasms
    • DOI 10.1034/j.1600-065X.2002.18805.x
    • KD Preuss C Zwick C Bormann F Neumann M Pfreundschuh 2002 Analysis of the B-cell repertoire against antigens expressed by human neoplasms Immunol Rev 188 43 50 10.1034/j.1600-065X.2002.18805.x (Pubitemid 35398864)
    • (2002) Immunological Reviews , vol.188 , pp. 43-50
    • Preuss, K.-D.1    Zwick, C.2    Bormann, C.3    Neumann, F.4    Pfreundschuh, M.5
  • 28
    • 0342940792 scopus 로고    scopus 로고
    • Serological identification of human tumor antigens
    • DOI 10.1016/S0952-7915(97)80053-2
    • U Sahin O Tureci M Pfreundschuh 1997 Serological identification of human tumor antigens Curr Opin Immunol 9 709 716 10.1016/S0952-7915(97)80053-2 (Pubitemid 27485301)
    • (1997) Current Opinion in Immunology , vol.9 , Issue.5 , pp. 709-716
    • Sahin, U.1    Tureci, O.2    Pfreundschuh, M.3
  • 29
    • 0036813331 scopus 로고    scopus 로고
    • Cancer/testis antigens: An expanding family of targets for cancer immunotherapy
    • DOI 10.1034/j.1600-065X.2002.18803.x
    • MJ Scanlan AO Gure AA Jungbluth LJ Old YT Chen 2002 Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol Rev 188 22 32 10.1034/j.1600-065X.2002.18803.x (Pubitemid 35398862)
    • (2002) Immunological Reviews , vol.188 , pp. 22-32
    • Scanlan, M.J.1    Gure, A.O.2    Jungbluth, A.A.3    Old, L.J.4    Chen, Y.-T.5
  • 30
    • 0037818503 scopus 로고    scopus 로고
    • Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
    • DOI 10.1182/blood-2002-08-2554
    • SM Schmidt K Schag MR Muller MM Weck S Appel L Kanz F Grunebach P Brossart 2003 Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells Blood 102 571 576 10.1182/blood-2002-08-2554 (Pubitemid 36841977)
    • (2003) Blood , vol.102 , Issue.2 , pp. 571-576
    • Schmidt, S.M.1    Schag, K.2    Muller, M.R.3    Weck, M.M.4    Appel, S.5    Kanz, L.6    Grunebach, F.7    Brossart, P.8
  • 36
    • 38049129212 scopus 로고    scopus 로고
    • Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
    • 10.1073/pnas.0710557105
    • L Vence AK Palucka JW Fay T Ito YJ Liu J Banchereau H Ueno 2007 Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma Proc Natl Acad Sci USA 104 20884 20889 10.1073/pnas. 0710557105
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 20884-20889
    • Vence, L.1    Palucka, A.K.2    Fay, J.W.3    Ito, T.4    Liu, Y.J.5    Banchereau, J.6    Ueno, H.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.